Solasodine

Solasodine

Overview

Solasodine is a steroidal spirosolane-type steroidal alkaloid and the aglycone of several solasodine glycoalkaloids (SGAs), including solasonine and solamargine. It is chiefly associated with Solanum species, including eggplant (S. melongena), S. laciniatum, and S. aviculare. Its importance is both pharmacognostic—as a characteristic secondary metabolite of Solanaceae—and pharmaceutical—as a steroidal starting material and experimental bioactive compound.

Botanical and pharmacognostic aspects

Taxonomy and distribution

• Family: Solanaceae
• Principal genus: Solanum
• Representative sources: S. aviculare, S. laciniatum, S. melongena, and other solasodine-containing species
• Plant parts: Concentrations vary with species, organ, developmental stage, genotype, cultivation conditions, and fruit maturity. Leaves, fruits, stems, and roots may contain steroidal glycoalkaloids; the aglycone is generally generated by hydrolysis of glycosides.

Solasodine-bearing plants should be distinguished from plants containing diosgenin. Both are steroidal raw materials, but solasodine has a nitrogen-containing steroidal alkaloid nucleus and requires a different chemical degradation sequence before conversion to steroid intermediates.

Chemical occurrence

In intact plants, solasodine commonly occurs predominantly in glycosylated forms rather than as free solasodine. Important glycoalkaloids include:

• α-Solasonine
• α-Solamargine
• Related solatriose- or chacotriose-containing glycoalkaloids

Hydrolysis removes the sugar residues and yields solasodine. Analytical reports must therefore specify whether they measure free solasodine, total solasodine after hydrolysis, or individual glycoalkaloids.

Biosynthesis and ecological role

Solasodine glycoalkaloids arise from steroidal metabolism and nitrogen incorporation, followed by glycosylation. In the plant, they are considered defensive metabolites, contributing to deterrence of herbivores and protection against some pathogens. Levels may change during ripening and in response to stress. This ecological function also explains why poorly characterized extracts may have a narrow safety margin.

Cultivation and production

The historical interest in solasodine-bearing plants is primarily due to their potential conversion into pharmaceutically important steroid compounds. Until the mid-1970s, steroidal starting materials were prepared almost exclusively from diosgenin; shortages and supply instability encouraged investigation of alternative sources. Solasodine was found to be a suitable starting material for degradation sequences leading to key steroid intermediates used in corticosteroid and contraceptive synthesis.

Among investigated species, S. aviculare has been reported as particularly promising, with S. laciniatum also receiving attention. Field production is affected by agricultural, environmental, genetic, and supply-chain constraints. Plant-cell, organ, and suspension-culture systems have consequently been studied as possible controlled sources of steroidal alkaloids. In vitro production may improve standardization and reduce pressure on natural populations, although scale-up, yield, precursor supply, elicitation, and downstream purification remain challenges.

Pharmacological aspects

Antineoplastic research

Solasodine and solasodine glycoalkaloid preparations have shown cytotoxic or antiproliferative effects in several in vitro cancer models. These findings should be interpreted as preclinical: activity in cultured cells does not establish clinical efficacy or therapeutic safety.

Retained lung-cancer invasion study

A study using human A549 lung-cancer cells examined the effect of solasodine on cell motility and invasion. The reported findings were:

• reduced A549-cell viability;
• marked suppression of invasion at doses described as non-toxic in the invasion assay;
• reduced mRNA expression of MMP-2, MMP-9, and EMMPRIN;
• increased expression of RECK, TIMP-1, and TIMP-2;
• suppression of PI3K and Akt phosphorylation; and
• downregulation of oncogenic miR-21.

The authors proposed that reduced miR-21 may increase RECK expression and thereby contribute to inhibition of matrix-metalloproteinase activity and cancer-cell invasion. The study supports a hypothesis of anti-invasive and possible anti-metastatic activity, but it was an in-vitro mechanistic study and does not demonstrate benefit in patients.

Study report: Solasodine inhibits invasion of human lung cancer cells through downregulation of miR-21 and MMP expression

Other investigated activities

Depending on the compound, extract, dose, and experimental model, solasodine or related glycoalkaloids have been investigated for:

• cytotoxic and pro-apoptotic effects;
• effects on cell-cycle progression;
• modulation of migration, invasion, and proteolytic enzymes;
• anti-inflammatory and immunomodulatory effects; and
• antimicrobial or antiparasitic activity.

Evidence is heterogeneous because solasodine, solasonine, solamargine, and crude Solanum extracts are not pharmacologically interchangeable. Glycosylation can substantially alter membrane interaction, absorption, potency, and toxicity.

Pharmacological mechanisms under investigation

Proposed mechanisms include modulation of PI3K/Akt signaling, miRNA expression, matrix metalloproteinases, apoptosis-related pathways, oxidative stress, and membrane-associated signaling. These mechanisms remain model-dependent and require confirmation in pharmacokinetic, animal, and clinical studies.

Pharmacokinetics and formulation considerations

Systemic pharmacokinetic data for purified solasodine are limited compared with conventional medicines. Key questions include oral absorption, metabolism, tissue distribution, protein binding, bioavailability, and elimination. Poor aqueous solubility and possible interaction with cell membranes may complicate formulation and contribute to dose-dependent toxicity. Standardized preparations should quantify both solasodine and the major glycoalkaloids, not rely solely on total extract mass.

Safety and toxicology

Steroidal glycoalkaloids can be toxic, particularly at high concentrations or when concentrated in unripe or damaged plant material. Potential effects include gastrointestinal irritation, nausea, vomiting, neurologic symptoms, and membrane-associated toxicity. Safety depends on the exact molecule, glycoside profile, dose, route, formulation, and patient factors.

Important precautions:

• Do not infer the safety of a traditional Solanum preparation from a cell-culture study of purified solasodine.
• Avoid self-medication with concentrated extracts or unripe plant material.
• Extra caution is warranted during pregnancy, breastfeeding, childhood, liver or kidney disease, and when multiple medicines are used.
• Clinically relevant drug-interaction and reproductive-safety data are insufficient.

Pharmaceutical significance

Solasodine is valuable as a semi-synthetic steroid precursor. Its steroidal framework can be chemically transformed into intermediates for corticosteroid- and contraceptive-related synthesis. This industrial role is distinct from claims that solasodine itself is an approved anticancer drug. Sustainable cultivation, chemotype selection, controlled extraction, hydrolysis, purification, and analytical standardization are central to developing reliable supply chains.

Analytical and quality-control considerations

A robust botanical or pharmaceutical specification should document:

• authenticated plant identity and voucher specimen;
• plant part and harvest maturity;
• cultivation and post-harvest conditions;
• extraction and hydrolysis procedures;
• chromatographic quantification of solasodine and principal glycoalkaloids;
• contaminants, adulterants, pesticides, microbes, and heavy metals; and
• batch-to-batch variability and stability.

HPLC or LC–MS methods are generally more informative than nonspecific color reactions. Because hydrolysis can convert glycosides into solasodine, sample preparation must be controlled and reported clearly.

Overall assessment

Solasodine is a botanically important Solanaceae steroidal alkaloid and a historically significant alternative steroid precursor. Its anticancer, anti-invasive, anti-inflammatory, and antimicrobial properties are promising but remain predominantly preclinical. The strongest retained evidence here is the A549 lung-cancer in-vitro study linking reduced invasion with miR-21, RECK/TIMPs, MMPs, and PI3K/Akt signaling. Translation to human therapy requires validated pharmacokinetics, toxicology, standardized botanical materials, animal efficacy studies, and controlled clinical trials.

Articles/Studies

• Solasodine inhibits invasion of human lung cancer cells through downregulation of miR-21 and MMP expression
• Background source on *Solanum aviculare* and *S. laciniatum* as solasodine sources

Evidence note: The linked materials are retained as source leads. Interpret therapeutic claims according to study design, and verify primary publications and current toxicology before clinical or commercial use.